![]()
|
[Frontiers in Bioscience, 5, d72-83, January 1, 2000]
|
|
|---|---|---|
![]() ![]() ![]()
|
CELLULAR AND MOLECULAR BASIS OF b-AMYLOID PRECURSOR PROTEIN METABOLISM Jeffrey P. Greenfield, Rachel S. Gross, Gunnar K. Gouras, and Huaxi Xu Fisher Center for Alzheimer Research and Laboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York NY 10021 TABLE OF CONTENTS
In molecular neurobiology, perhaps no molecule has been as thoroughly examined as Alzheimer's b-amyloid precursor protein (bAPP). In the years since the cDNA encoding bAPP was cloned, the protein has been the subject of unparalleled scrutiny on all levels. From molecular genetics and cellular biology to neuroanatomy and epidemiology, no scientific discipline has been left unexplored - and with good reason. b-amyloid (Ab) is the main constituent of the amyloidogenic plaques which are a primary pathological hallmark of Alzheimer's disease, and bAPP is the protein from which Ab is cleaved and released. Unraveling the molecular events underlying Ab generation has been, and remains, of paramount importance to scientists in our field. In this review we will trace the progress that has been made in understanding the molecular and cellular basis of bAPP trafficking and processing, or alternatively stated, the molecular basis for Ab generation. Imperative to a complete understanding of Ab generation is the delineation of its subcellular localization and the identification of proteins that play either direct or accessory roles in Ab generation. We will focus on the regulation of bAPP cleavage through diverse signal transduction mechanisms and discuss possible points of therapeutic intercession in what has been postulated to be a seminal molecular step in the cascade of events terminating in the onset of dementia, loss of neurons, and eventual death from Alzheimer's disease. |